Tesamorelin 5mg

€54.99

Technical Specifications

Specification	Detail
Product Name	Tesamorelin (TH9507, GHRH Analog)
Quantity	5mg per vial
Purity	≥99% (HPLC verified)
Form	Lyophilized powder
Appearance	White to off-white lyophilized powder
Molecular Weight	5135.9 g/mol
CAS Number	218949-48-5
Amino Acid Length	44 amino acids
Biological Functions	GHRH receptor agonist, GH secretagogue, IGF-1 elevation
Key Target Tissues	Pituitary, liver, adipose tissue, muscle
Storage (Lyophilized)	≤6°C to -20°C; protect from light and moisture
Storage (Reconstituted)	2-8°C for short-term; -80°C for long-term, aliquot
Shelf Life	24 months from manufacture date
Shipping	Ambient temperature with protective packaging
Intended Use	Research and laboratory use only
Documentation	Certificate of Analysis provided with each batch

Categories: Buy Peptide Online EU, Buy Peptide Online UK Tags: #paresthesia, ≥8% reduction, 3C, 3rs principles, 4C, 5°C, 5mg peptide, 99% purity peptide, A1 pulley, AA amyloidosis, aarhus university, abaloparatide, ABCA1, ABCG1, abdominal fat, abemaciclib, acanthosis nigricans, ACC acetyl CoA carboxylase, accelerators, accurate results, ACE inhibitors, acetylation, acquired lipodystrophy, acquisition, active life expectancy, activities of daily living ADL, Activities specific Balance Confidence ABC scale, acute coronary syndrome ACS, acute kidney injury AKI, adaptation, adenylate cyclase, adipocyte research, Adipogenesis, adiponectin ELISA, adiponectin research, adipose tissue quality, adipose triglyceride lipase, adipose-derived stem cells, adjunctive therapy, adjuvant chemotherapy, adjuvant therapy, adolescent health, adoptive cell therapy, adrenal insufficiency, adrenergic receptors, adverse events monitoring, aging research, AI artificial intelligence, AIDS research, AKT2 mutations, AL amyloidosis, albuminuria, aldosterone, aldosterone antagonists, alendronate, all cause death, all cause mortality, allosteric modulators, alpelisib, alpha 1, alpha 2, alpha synuclein, ALS, Alzheimer's disease, amino acid sequence 44aa, AMPK activation, amyloid, anabolic research, analytical standard, ANCA associated vasculitis, androgen deprivation therapy ADT, androgen receptor AR, angel investors, angiotensin II, animal model testing, animal study compounds, animal welfare, annular pulley, antagonistic pleiotropy, anterior canal BPPV, Anterior pituitary, anthropometric measurements, anti GBM disease, anti-aging peptides, anti-inflammatory peptides, anticoagulation, antihypertensive medications, antioxidant enzymes, antiphospholipid syndrome, antiplatelet agents, antiretroviral therapy research, antisaccades, antiviral therapy, apixaban, apoA1, apoB, apoC3, apoE genotype, APOE2, APOE3, APOE4, APOL1 risk variants, apolipoproteins, Apoptosis research, apposition, apraxia, APRI score, ARBs, architectural proteins, ARE antioxidant response element, ART complications, arteriosclerosis, arthralgia, arXiv, aspirin, assisted reproduction, astrocyte activation, ATAC-seq, atezolizumab, ATGL, atherogenic dyslipidemia, atherosclerosis, athetosis, atrial natriuretic peptide ANP, atypical HUS aHUS, Austria peptides, autoimmune disease, autonomic function, Autonomous Madrid, autophagy induction, Autophagy research, avelumab, Babinski sign, bacteriostatic water, balance training, ballismus, bank transfer, barbecue roll, bare metal stent BMS, baroreflex sensitivity, Barraquer-Simons syndrome, basal like, Belgium research chemicals, bench to bedside, benign nephrosclerosis, Berg balance scale, BERT bidirectional encoder representations from transformers, beta 1, beta 2, beta 2 microglobulin, beta 3, beta amyloid, Beta arrestin, beta blockers, beta oxidation, Biased signaling, bilateral coordination, Bile acid metabolism, binding affinity, biochemicals, biodemography, biologics research, Biomarker driven, biomarker research, biomarker validation, biomedical NLP, bioresorbable scaffold, bioRxiv, biotech marketplace, biotech research Europe, biotech startups, bisphosphonates, blinding, Blood brain barrier, blood pressure, BMI research, BNP, body composition analyzer, body composition research, body image dissatisfaction, body image research, body volume index, bone density research, bone mineral density BMD, box and block test, BPC-157 Europe, BPPV benign paroxysmal positional vertigo, brain aging, Brain delivery, branded peptide research, Brandt Daroff exercises, breast cancer, Breast Cancer Index, breast milk composition, budget impact analysis, buffalo hump research, buy GHRH peptides, buy peptide online, buy peptides EU, buy peptides online Europe, Buy Research Peptides EU, Buy Tesamorelin 5mg Online, C3 glomerulonephritis, C3 glomerulopathy, CABG coronary artery bypass graft, cachexia models, cachexia treatment, CADTH Canada, calcitonin, calcium channel blockers, calcium deficiency, Caloric restriction, calorie restriction mimetics, cAMP stimulation, canalithiasis, cancellation of VOR, cancer vaccines, capture C, CAR T cell, carbohydrate restriction, cardiac function, Cardiac output, cardiorenal syndrome, cardiovascular death, cardiovascular mortality, Cardiovascular research, cardiovascular risk, carotid intima media thickness, carpal tunnel syndrome, Case control, catalase, catecholamines, CCl4, CD2AP, CD8A research, CDK4/6 inhibitors, cell culture peptides, cell painting assay, cell survival, centenarians, central obesity, central vertigo, cerebellar tremor, cerebral microbleeds, CETP cholesteryl ester transfer protein, chaperones, Charite Berlin, checkout securely, checkpoint inhibitors, chemical biology, chemical castration, chemical genetics, chemokines CCL3, childhood obesity, chin tremor, ChIP-seq, CHMP, cholesterol HDL LDL, cholesterol metabolism, Cholesterol research, chondrocyte research, chorea, chromatin immunoprecipitation ChIP, chromatin loops, Chromatin remodeling, chromosome conformation capture, chromosome territories, chronic kidney disease CKD, chronotropy, chuck pinch, Churg Strauss syndrome, chylomicronemia syndrome, circadian rhythms, circulating tumor cells CTCs, circulating tumor DNA ctDNA, Cirrhosis, citation database, claudin low, clinical endocrinology, clinical endpoint, clinical guidelines, clinical NLP, clinical oncology research, clinical translation, clinical trial compounds, clock genes, clonus, clopidogrel, CNRS France, co development, co marketing, CoA peptide, coagulation cascade, cognitive decline, Cognitive function, cogwheel rigidity, cohesin, cohort studies, Collagen synthesis, collapsing glomerulopathy, Colles fracture, combination therapy, competitive binding, complement alternative pathway, complement mediated, compliance monitoring, compression of morbidity, computational biology, concentric remodeling, consensus statements, conservative treatment, constructional apraxia, contract research organizations CRO, contrast induced nephropathy, convolutional neural networks CNNs, coordination, copyrights, coronary calcium score, coronary revascularization, cortical thickness, corticosteroid injection, cortisol rhythm, cost, Cost effectiveness analysis, CPT1 carnitine palmitoyltransferase, Crawford small parts dexterity test, creatinine, CREB phosphorylation, Credit card, critical illness, Cross sectional, crossover design, cruciate pulley, cryoglobulinemia, Cryptocurrency, CSF levels, CT scan research, CTCF, CTLA 4 inhibitors, cupulolithiasis, curve fitting, custom peptide synthesis, Customer support, cytochrome P450 research, cytokine multiplex assays, cytokine research, cytokine therapy, Czech Republic peptides, D-dimer, dabigatran, De Quervain tenosynovitis, decision trees, deep learning, degarelix, delayed graft function, dementia free survival, Denmark research peptides, denosumab, dense deposit disease DDD, depot formulation, deterministic sensitivity analysis, developmental origins of health and disease DOHaD, DEXA scan research, DHEA, diabetes metabolism journal, diabetes research Europe, diabetic nephropathy, dialysis, dialysis related amyloid, diastolic BP, diastolic function, diet intervention, differentiation, disability, disablement process, discreet shipping, discrete event simulation, disposable soma theory, disposal guidelines, diuretics, DNA methylation, DOACs direct oral anticoagulants, docking studies, dopamine, dorsocervical fat pad, dose ranging studies, Dose response, dosing schedule, DPP4 resistance, dressing apraxia, dromotropy, dropout rates, drug development pipeline, drug development tool, Drug discovery, drug eluting stent DES, drug interaction research, drug pricing, drug screening, drug screening platforms, dual antiplatelet therapy DAPT, dual energy X-ray, Dunnigan variety, Dupuytren contracture, durvalumab, Dutch shipping, DVT deep vein thrombosis, DXA scan, Dynamic Gait Index DGI, dysbetalipoproteinemia, dystonia, E/A ratio, E/e' ratio, EC50, eccentric hypertrophy, echocardiography, echoMRI, economic modeling, edema, edoxaban, efficacy studies, eGFR, EGRIFTA research, Ejection fraction, elderly, electron microscopy, ELF test, ELISA kits, EMA approved, EMA guideline, Embryo development, endocrine research, endocrine therapy, endocrinology lab, endometrial thickness, endoplasmic reticulum stress, EndoPredict, Endothelial dysfunction, endothelial function, endothelial lipase, endothelin, energy expenditure, enhanced liver fibrosis panel, enhancer promoter interactions, eNOS, eosinophilic granulomatosis with polyangiitis EGPA, EPFL, epidemiological research, Epigenetics, epinephrine, epistasis, eplerenone, Epley maneuver, ER stress, ERK pathway, essential tremor, estrogen, estrogen receptor ER, ETH Zurich, ethnicity research, EU based warehouse, EU directive 2010/63, EU peptide shop, euglycemic clamp studies, eupeptideshop.org, European e-commerce, European Medicines Agency, European peptide vendor, event extraction, everolimus, evidence based research, evidence-based practice, evolutionary biology, Ex vivo research, exceptional longevity, exercise intervention, Exercise training, exit strategy, exosomes, extension studies, extracellular vesicles, eye hand coordination, factor H, factor I, factor VIII, fall prevention, fall risk, falls, Falls Efficacy Scale FES, familial amyloid, familial partial lipodystrophy, fast delivery Europe, fast track designation, Fasting mimicking diet, fat atrophy, fat breakdown, fat density Hounsfield units, fat hypertrophy, fat loss, Fat oxidation, fat redistribution, fat tolerance test, fatty acid synthase, fatty casts, fatty liver research, FDA approved research, FDA guidance, Fertility research, Fetal programming, FIB-4 index, fibrinogen, fibrinolysis, FibroScan, Fibrosis research, fibrosis staining, fine motor control, Finland peptides, first-in-human, flexor digitorum profundus FDP, flexor digitorum superficialis FDS, flexor pollicis longus FPL, flexor tenosynovitis, flow cytometry, Flow mediated dilation, Flutter, focal global glomerulosclerosis, focal segmental glomerulosclerosis FSGS, fondaparinux, food intake studies, foot process effacement, FOR RESEARCH USE ONLY, FPLD2, fragility fracture, frailty research, Framingham risk score, France peptides supplier, Fredrickson classification, free fatty acids, free radical theory, French logistics, frontotemporal dementia FTD, functional assays, functional outcomes, functional reach test, FXR, G protein signaling, gait apraxia, gamete quality, gaze holding, gegenhalten, gender research, gene expression, gene expression profiling, generative adversarial networks GANs, generic tesamorelin, genetic interactions, genetic lipodystrophy, genome organization, genomic grade index, genomics research, geriatric research, German warehouse, Germany research chemicals, gestational diabetes, GH ELISA, GH pulsatility, GH3 cells, Ghent University, GHRF, GHRH analog, GHRH analogs for sale, glomerular basement membrane GBM, glomerulonephritis, GLP good laboratory practice, GLP-1 research peptides EU, glucose homeostasis, glucose uptake research, glutathione, glutathione peroxidase, GM-CSF, GMP grade, GnRH agonist, GnRH antagonist, Goodpasture syndrome, goserelin, GPT generative pre trained transformer, grant writing, granular casts, granulomatosis with polyangiitis GPA, GRF 1-44, GRF agonists, GRF receptor, grip strength, grooved pegboard, growth hormone releasing hormone, growth spurt, growth trajectories, Gs alpha, Gufoni maneuver, GZMA research, habituation, half-life extension, hand function, hand tool dexterity, handicap, handling guidelines, hard outcomes, HAS France, HDL biogenesis, head impulse nystagmus test of skew, head impulse test, head tremor, health span, health technology assessment HTA, Healthy aging, heart failure HF, heart rate, heart rate variability HRV, Heat Shock Proteins Hsp70, heavy chain deposition disease HCDD, Heidelberg University, hematuria, hemiballismus, hemodialysis, hemolytic uremic syndrome HUS, hemophilia, heparin, heparin releasable LPL, hepatic lipase, hepatic outcomes, Hepatic steatosis, hepatitis B associated, hepatitis C associated, hepatocellular carcinoma, hepatocyte research, HER2 neu, hereditary amyloid, hexenoic acid, HFpEF, HFrEF, Hi-C, high content screening HCS, high purity peptide, high purity peptides Germany, high-throughput screening, HINTS exam, hip fracture, hippocampal volume, histology liver, Histone modification, histopathology, histrelin, hit-to-lead, HIV associated nephropathy HIVAN, HIV associated neurocognitive disorder HAND, HIV lipodystrophy research, HIV research, Hoffman sign, Holmes tremor, HOMA-IR research, horizontal canal BPPV, hormesis, hormone replacement therapy HRT, hormone sensitive cancer, hormone sensitive lipase, HPA axis, HPLC analysis, HPLC peptide purity, hsCRP, HSP90, human embryonic kidney cells, human IGF-1, Hungary lab supplies, Huntington's disease, hyperandrogenism, hyperinsulinemic clamp, hyperlipoproteinemia, hypermetric saccades, hyperparathyroidism, hypersensitivity, hypertension, hypertensive arterionephrosclerosis, hypertensive nephrosclerosis, hypertriglyceridemia, hypocaloric diet, hypometric saccades, Hypothalamus research, IACUC guidelines, ibandronate, IC50, ICER incremental cost effectiveness ratio, ICU acquired weakness, ideational apraxia, ideomotor apraxia, IgA nephropathy, IGF-1 binding proteins, IGF-1 research, IL-2, IL-6, image based screening, immortalized cell lines, immune complex mediated, immune exhaustion, immune modulation peptides, immune pathways, immunofluorescence, immunohistochemistry, immunotherapy, impact factor research, implantation, implementation science, in vitro alternatives, in vitro research, in vivo research, incidence rates, incubators, indirect calorimetry, infant nutrition, infectious diseases, Inflammatory markers, information extraction, injection site reactions, innovation labs, inotropy, INSERM, instrumental ADL, insulin receptor mutations, insulin sensitivity research, Insulin syringe, insulin tolerance test ITT, intellectual property, intention tremor, interchromosomal interactions, interferon alpha, interleukin 8, Intermittent fasting, intranasal research, intravenous fat tolerance, intrinsic subtypes, investigational peptide, IP injection research, ipilimumab, IPO initial public offering, IQWiG Germany, Ireland peptides, Italy research compounds, IV injection research, IVF, JAK-STAT, Jebsen Taylor test, Jet lag, journal submission, Karolinska Institute, key pinch, Ki values, kidney transplant, kinetic tremor, knowledge translation, KU Leuven, lab exchange, lab tested peptide, laboratory equipment supplier, laboratory peptides Netherlands, laboratory reagent, laboratory standards, lactation, lacunar infarcts, LADs lamina associated domains, lamin A/C, large language models LLMs, late lumen loss, lateral pinch, LDL receptor, lead optimization, lead pipe rigidity, lean mass assessment, lean mass preservation, learning models, left ventricular hypertrophy LVH, Leibniz Institute, Leiden University, leuprolide, Lewy bodies, licensing agreements, life sciences, lifespan, lifestyle modification, light chain amyloid, light chain cast nephropathy, light chain deposition disease LCDD, light microscopy, limb fat, limb kinetic apraxia, lipid clearance, Lipid metabolism, lipid oxidation, lipid panel, lipid profile research, lipodystrophy syndrome, lipogenesis, lipohyalinosis, lipolysis peptides, lipolysis regulation, lipolysis stimulation, lipoprotein lipase, lipoprotein particles, liquid biopsy, literature mining, liver enzymes ALT AST GGT, liver health research, liver transplantation, LMNA gene, lmu munich, LMWH, long noncoding RNAs, long term safety, Longevity research, longitudinal studies, luminal A, luminal B, lupus nephritis, lusitropy, LXR, lyophilized peptide, lysosomal function, MACE major adverse cardiac events, machine learning, macroalbuminuria, macronutrient composition, macrosomia, major adverse cardiovascular events MACE, malignant hypertension, MammaPrint, manipulation, manual dexterity, manuscript preparation, MAP kinase, marketing authorization, Markov models, mass spec analysis, Maternal obesity, Max Planck Institute, maximum lifespan, MCP CD46, meal challenge, mean arterial pressure, mean lifespan, mediators, medical research council, medication adherence, medicinal chemistry, Mediterranean diet, medRxiv, melatonin research, membranoproliferative glomerulonephritis MPGN, membranous nephropathy, memory guided saccades, memory research, Mental health, merger, mesenchymal stem cells, meta-analysis systematic review, metabolic cage studies, metabolic chambers, Metabolic Disorder Research, metabolic inflammation, metabolic research peptides, metabolic syndrome X, metabolism research, Metabolomics Research, metastatic disease, metformin, metformin comparison, methylation, microalbuminuria, microglial activation, microRNAs, microscopic polyangiitis MPA, microsimulation, microspheres, middle age, mild cognitive impairment MCI, milestone payments, mineralocorticoid receptor, minimal change disease, Minnesota manual dexterity test, mitochondria biogenesis, mitochondrial research, Mitophagy, mixed cryoglobulinemia, mixed dementia, mixed hyperlipidemia, molecular biology, molecular dynamics, molecular subtypes, Molecular tumor board, monoclonal gammopathy, monoclonal gammopathy of renal significance MGRS, monoclonal immunoglobulin deposition disease MIDD, monocyte research, morphological profiling, Morris water maze, mortality research, motor examination, motor neuron disease, motor planning, mouse models, MRI research, MS verified peptides, MSDS safety data sheet, mTOR inhibition, mTOR inhibitors, mTOR signaling, multiple myeloma, muscle protein synthesis, muscle wasting research, myalgia, myeloma kidney, myocardial infarction MI, N-terminal modification, NAD+ precursors, NADs nucleolus associated domains, NAFLD fibrosis score, NAFLD research, named entity recognition NER, nanoparticle encapsulation, NASH research, natural language processing NLP, negative feedback loop, neoadjuvant chemotherapy, neoadjuvant therapy, neointimal hyperplasia, neonatal body composition, nephrin, nephritic syndrome, nephrotic syndrome, nephrotoxicity, Netherlands lab supply, neural networks, neurocognitive impairment research, neurodegeneration, Neuroinflammation, neurological examination, neuronal health, neuroprotection, next generation sequencing NGS, NICE UK, Nicotinamide Riboside, nine hole peg test, niraparib, nitric oxide, nivolumab, NMN, NMR based analysis, NMR lipoprofile, non responder analysis, non-peptide agonists, noninvasive markers, Norepinephrine, Norway research chemicals, Not for human consumption, Novel object recognition, NR, Nrf2 pathway, NSAIDs, NSTEMI, NT-proBNP, nuclear lamina, nuclear receptors, nuclear signaling, nystagmus, O'Connor finger dexterity test, obesity research, observational research, occupational therapy, oculopalatal tremor, Oil Red O staining, olaparib, oncolytic viruses, Oncotype DX, online peptide store, open access, open release, open-label extension, opposition, opsoclonus, optokinetic nystagmus OKN, oral glucose tolerance test OGTT, orchiectomy, Order peptides online, orphan drug designation, orthostatic tremor, osteoblast research, osteomalacia, osteopenia, osteoporosis, osteoporotic fracture, oval fat bodies, ovulation induction, oxidative stress, PAI-1, pair feeding, pair feeding studies, palatal tremor, palbociclib, palmar pinch, PAM50, pancreatic clamp, parallel design, parasympathetic nervous system, parathyroid hormone PTH, paratonia, Paris Cite, Parkinson's disease, Parkinsonian tremor, PARP Inhibitors, partial lipodystrophy, PAS stain, patents, patient stratification, patient-reported outcomes, payment methods EU, PayPal, PBAC Australia, PCI percutaneous coronary intervention, pCREB, PCSK9, PD 1 inhibitors, PD L1 inhibitors, PE pulmonary embolism, Pediatric research, peer review, PEGylation, pembrolizumab, peptide calculator, peptide delivery systems, peptide design, peptide drug development, peptide forum EU, peptide half-life, peptide handling, peptide hormones, peptide library, peptide mimetics, peptide protocol, Peptide quality control, Peptide reconstitution, peptide research applications, peptide shipping, peptide shop Europe, Peptide solubility, Peptide stability, Peptide storage, peptide supplier Spain, peptide synthesis Europe, peptide therapeutics, peptides for research France, percutaneous release, perilipin, peripheral vertigo, peritoneal dialysis, personalized medicine, PGC1 alpha, pharma partnership, pharma R&D, pharmaceutical testing, pharmacoeconomics, Pharmacogenomics, phase I trials, phase III research, Phenotypic screening, phospholipase A2 receptor PLA2R, phospholipid transfer protein, phosphorylation, physical function, physical therapy, phytochemicals, PI3K Akt Pathway, PI3K inhibitors, picrosirius red, pinch strength, pituitary cell lines, Pituitary research, Placebo controlled, placental function, plasminogen, platelets, plethysmography, podocin, podocytes, Poland research chems, policy statements, polycystic ovary syndrome PCOS, polyglutamine, Portugal research compounds, position papers, post ICU syndrome, posterior canal BPPV, postprandial lipemia, postural control, postural tremor, potassium excretion, power analysis, PPAR alpha, PPAR gamma, PPARG mutations, prasugrel, praxis, pre-clinical research, precision medicine, precision oncology, precision research, predictive saccades, prehension, preprint servers, preservation of lean mass, prevalence studies, primary amyloidosis, Primary Cell Culture, primary hyperparathyroidism, Primate research, probabilistic sensitivity analysis, Progenitor Cells, progesterone, progesterone receptor PR, promoter capture Hi C, Prosigna, prostacyclin, prostate cancer, protein aggregation, protein intake, protein kinase A, Protein synthesis, proteinuria, proteolytic stability, Proteomics Research, proteostasis, protocol assistance, psychogenic tremor, psychological burden, PTH analog, puberty, PubMed mining, PubMed research, pulley system, pulse pressure, Purdue pegboard, pursuit, QALY quality adjusted life year, qualification process, quality of life questionnaires, quality of life research, Radial arm maze, radial positioning, radioligand assays, raloxifene, randomization, RANKL inhibitor, rapamycin, rash, rat somatotrophs, rat studies, rat/mouse IGF-1, rational design, RBC casts, reactive oxygen species ROS, real-time PCR, real-world evidence, receptor binding assays, reconstitution calculator, recovery, rectangularization of survival curve, recurrent neural networks RNNs, reference standard, reflexes, refrigerated peptide, Regenerative medicine, registry studies, Regulatory affairs, Regulatory science, rehabilitation, reimbursement, relation extraction, renal biopsy, renin angiotensin system, Replacement refinement reduction, reproducible data, Reproductive endocrinology, research chemical supplier, research chemicals EU compliant, Research community, research dissemination, research ethics, research grade distinction, Research peptide vial, research peptides for sale, research protocol, research tools, Respiratory quotient, responder analysis, restenosis, resting tremor, resveratrol, revenue sharing, reverse cholesterol transport, ribociclib, rickets, rigidity, risedronate, risk factors, risk stratification, rivaroxaban, RNA-seq, Romberg test, romosozumab, royalty payments, rubral tremor, rucaparib, RXR, saccades, saccadic intrusions, saccadic latency, saccadic oscillations, saccadic velocity, Safety pharmacology, safety trials, sample size calculation, Sapienza Rome, SAR structure activity relationship, Sarcopenia Research, SAT subcutaneous adipose tissue, scientific advice, scientific exchange, scientific integrity, Scientific literature, scientific supply store, scientific writing, sclerostin inhibitor, Scopus indexed, screening library, secondary amyloid, secondary hyperparathyroidism, seed funding, Semont maneuver, senile systemic amyloid, sensitivity analysis, sensory examination, series A, series B, SERM selective estrogen receptor modulator, serum amyloid A, severe hypertriglyceridemia, severe insulin resistance, sex differences, SF-36, sharpened Romberg, Shift work, silver stain, single leg stance, SIRT1, sirtuins, SLE, Sleep deprivation, slit diaphragm, small dense LDL, small vessel disease, smooth pursuit, social burden, SOD superoxide dismutase, SOD1, sodium retention, Somatotroph cells, somatotropic axis, Sorbonne University, Spain research compounds, Spanish distribution, spasticity, spermidine, spin off companies, spironolactone, splinting, square wave jerks, SR-BI, startup companies, STAT proteins, statistical analysis, steatosis research, stem cell research, STEMI, stenosing tenosynovitis, stent thrombosis, stent types, stereotypies, sterile peptide, sterile peptide vials, sterile water, stigma research, stockholm university, strength testing, stress response, stretch enhancers, Stroke volume, strontium ranelate, subcutaneous injection research, subjective cognitive decline, substitution, successful aging, SUMOylation, super enhancers, surgical release, surrogate biomarkers, Surrogate endpoint, Sustained release, Sweden lab supplies, Switzerland peptides, sympathetic nervous system, synthetic dosage lethality, synthetic GHRH, synthetic lethality, systolic BP, T-cell activation research, T-score, talazoparib, talimogene laherparepvec, tandem stance, target lesion revascularization TLR, target vessel revascularization TVR, target-based screening, targeted therapy, tau, TDP-43, Technical support, technology transfer, tendon sheath, tenolysis, tenosynovectomy, teriparatide, tertiary hyperparathyroidism, Tesamorelin, Tesamorelin 5mg, Tesamorelin acetate, tesamorelin EU supplier, tesamorelin Europe, tesamorelin for research, tesamorelin France, tesamorelin Germany, tesamorelin Netherlands, tesamorelin price, tesamorelin Spain, testosterone, testosterone replacement, text mining, TH9507, therapeutic peptide, therapeutic strategy, thermogenesis research, thiazolidinediones, Third party tested, three jaw chuck, thrombosis, thrombosis risk, thrombospondin type 1 domain containing 7A THSD7A, thrombotic microangiopathy TMA, thrombotic thrombocytopenic purpura TTP, thromboxane, ticagrelor, tics, TIL therapy, Time restricted feeding, timed up and go TUG, tip pinch, TNF-alpha, tolerability, tongue tremor, topologically associating domains TADs, tornado diagrams, toxicology studies, tPA, trade secrets, trademarks, trans interactions, transcriptional coactivators, transcriptomics liver tissue, transfection studies, transient elastography, transition medicine, translational oncology, Translational research, transthyretin TTR, transvection, treadmill studies, treatment algorithm, treatment satisfaction, tremelimumab, tremors, trichrome stain, trigger digit, trigger finger, trigger thumb, triglyceride lowering, triglyceride research, triglycerides, triple negative breast cancer TNBC, triptorelin, TRPC6, trunk fat, tumor-infiltrating lymphocytes, TVEC, type I MPGN, type II MPGN, type III MPGN, type IV hyperlipidemia, ubiquitination, unfolded protein response UPR, university hospital research, University of Amsterdam, University of Barcelona, University of Copenhagen, University of Helsinki, University of Milan, University of Oslo, University of Vienna, university research EU, unstable angina, urticaria, uterine receptivity, VaD, vagal tone, vascular dementia, vascular resistance, VAT reduction, VAT responders, venous thromboembolism VTE, venture capital VC, vertebral compression fracture, vestibular rehabilitation, vestibulo ocular reflex VOR, visceral adipose tissue, visual fixation, vitamin D deficiency, voice tremor, voluntary running, von Willebrand factor, Waist circumference, waist-to-hip ratio, warfarin, water soluble peptide, WBC casts, Web of Science, weight loss, Western blot, where to buy tesamorelin, white matter hyperintensities, white papers, WHO ICF model, whole exome sequencing WES, whole genome sequencing WGS, wild type TTR, willingness to pay threshold, wrist fracture, writing tremor, xenohormesis, young adults, youth medicine, Z-score, ZIN Netherlands, zoledronic acid

Description

Premium Tesamorelin Peptide for Sale | 5mg Lyophilized Powder | ≥99% Purity | 48-Hour Delivery Across EU & UK

Tesamorelin: The Synthetic GHRH Analog at the Forefront of Metabolic Research

Buy Tesamorelin 5mg Online EU & UK, eupeptidelap.co.uk is proud to present Tesamorelin 5mg, a premium research-grade growth hormone-releasing hormone (GHRH) analog manufactured to the highest analytical standards. As a trusted peptide vendor uk and leading EU peptide supplier, we provide researchers across Europe with Tesamorelin for sale that delivers exceptional purity, consistency, and documented quality for advanced studies in endocrinology, metabolic regulation, and adipose tissue biology .

Tesamorelin is a synthetic 44-amino acid polypeptide analogue of growth hormone-releasing hormone (GHRH), engineered with a specific modification (a trans-3-hexenoyl group) that enhances its stability and resistance to enzymatic degradation in the bloodstream, resulting in a longer half-life and more sustained effect compared to its natural counterpart . With a molecular formula of C₂₂₁H₃₆₆N₇₂O₆₇S and a molecular weight of approximately 5135.9 g/mol, this sophisticated peptide is identical in sequence to human GHRH but with improved pharmacokinetic properties .

Tesamorelin works by binding to GHRH receptors on somatotroph cells in the anterior pituitary gland, stimulating the synthesis and pulsatile release of endogenous growth hormone (GH) . This pulsatile release mimics the body’s natural pattern of GH secretion, which is critical for its beneficial metabolic effects and helps avoid the continuous supraphysiological levels associated with direct growth hormone administration . The released GH subsequently stimulates hepatic production of insulin-like growth factor-1 (IGF-1), which mediates many of the peptide’s anabolic and metabolic actions on target cells including chondrocytes, osteoblasts, myocytes, hepatocytes, and adipocytes .

For researchers seeking to buy peptide online EU for investigations into visceral adipose tissue reduction, metabolic disorders, or age-related endocrine changes, eupeptidelap.co.uk offers this premium research compound with comprehensive documentation, including Certificates of Analysis and batch-specific purity data. Whether your laboratory is based in London, Berlin, Paris, or anywhere in the European Union, our guaranteed 48 hour delivery peptide service ensures your research continues without interruption.

The Scientific Foundation of Tesamorelin Research

Development and Clinical Background

Tesamorelin was developed as a targeted therapy for HIV-associated lipodystrophy, a condition characterized by abnormal fat redistribution including visceral fat accumulation, and received US Food and Drug Administration approval in 2010 under the brand name Egrifta for reducing excess abdominal fat in HIV-infected patients with lipodystrophy . Its unique mechanism of restoring pulsatile GH secretion offers a more physiological approach to addressing GH deficiency compared to direct GH administration. Buy Tesamorelin 5mg Online EU & UK

Mechanism of Action: GHRH Receptor Activation

Tesamorelin exerts its effects through selective activation of GHRH receptors on pituitary somatotroph cells . This activation initiates a cascade of endocrine events:

Pituitary Stimulation: After subcutaneous administration, tesamorelin binds to specific GHRH receptors on the surface of pituitary cells called somatotrophs, triggering the synthesis and release of growth hormone .

Pulsatile GH Release: The stimulation results in a significant yet pulsatile increase in circulating GH levels, preserving the body’s natural secretion pattern characterized by periodic bursts, primarily during sleep . This physiological pattern is critical for optimizing metabolic benefits while potentially mitigating side effects associated with continuous high-level GH exposure .

IGF-1 Production: The released GH travels to the liver, its primary target organ, where it stimulates production and secretion of insulin-like growth factor-1 (IGF-1), a primary mediator of GH’s anabolic and metabolic effects throughout the body .

Selective Receptor Binding: In vitro studies demonstrate that tesamorelin binds and stimulates human GRF receptors with similar potency as endogenous GHRH .

Pharmacokinetic Profile

Tesamorelin exhibits unique pharmacokinetic properties that distinguish it from other GHRH analogs:

Parameter	Value
Absolute Bioavailability	<4% after subcutaneous administration
Peak Concentration (Tmax)	Median 0.15 hours (approximately 9 minutes)
Half-Life (t½)	Approximately 11 minutes in healthy subjects
Volume of Distribution	4.8 ± 1.9 L/kg
Metabolism	No formal metabolism studies performed in humans; metabolized locally by receptor-bearing cells
Elimination	Rapid clearance from circulation

Notably, tesamorelin exposure (AUC) is approximately 34% higher in HIV-infected patients than healthy subjects, while peak plasma concentrations remain similar between populations .

Selectivity Profile

Tesamorelin demonstrates remarkable selectivity for the GH axis. Clinical trials have shown no clinically significant changes in levels of other pituitary hormones, including thyroid-stimulating hormone (TSH), luteinizing hormone (LH), adrenocorticotropic hormone (ACTH), and prolactin . This selectivity minimizes confounding variables in endocrine research applications.

Key Research Applications

Visceral Adipose Tissue (VAT) Research

Tesamorelin’s most extensively documented effect is its ability to selectively reduce visceral adipose tissue, the metabolically active deep abdominal fat surrounding vital organs that contributes significantly to metabolic disease, inflammation, and cardiovascular risk . A comprehensive meta-analysis of randomized controlled trials published in 2026 demonstrated:

Significant VAT Reduction: Tesamorelin treatment was associated with significant reduction in visceral adipose tissue (mean difference = -27.71 cm², 95% CI [-38.37, -17.06]; P < 0.001)
Trunk Fat Decrease: Mean reduction of -1.18 kg (95% CI [-1.40, -0.96]; P < 0.001)
Waist Circumference Reduction: Mean decrease of -1.61 cm (95% CI [-2.28, -0.95]; P < 0.001)
Selective Targeting: Tesamorelin selectively targets visceral fat with minimal to no effect on beneficial subcutaneous adipose tissue

In landmark Phase 3 trials, patients receiving daily 2 mg injections of tesamorelin for 26 weeks experienced statistically significant reductions in VAT averaging approximately 15-18% . Extension studies demonstrated that continued treatment for up to 52 weeks led to sustained reductions, though VAT levels began to return toward baseline upon cessation, indicating that ongoing therapy is necessary to maintain benefits. Buy Tesamorelin 5mg Online EU & UK

Hepatic Fat Research

Emerging evidence supports tesamorelin’s efficacy in reducing hepatic fat accumulation, making it valuable for research into metabolic dysfunction-associated steatotic liver disease (MASLD):

Hepatic Fat Reduction: The 2026 meta-analysis demonstrated significant reduction in hepatic fat percentage (mean difference = -4.28%, 95% CI [-6.31, -2.24]; P < 0.001)
Mechanism: GH directly stimulates lipolysis in hepatocytes and reduces de novo lipogenesis
Clinical Relevance: Hepatic lipid accumulation is a critical health concern associated with increased cardiovascular risk

Body Composition and Lean Mass Research

Beyond fat reduction, tesamorelin has demonstrated significant anabolic effects on lean body mass:

Lean Body Mass Increase: Meta-analysis revealed significant increase in lean body mass (mean difference = 1.42 kg, 95% CI [1.13, 1.71]; P < 0.001)
Muscle Quality: Research indicates tesamorelin decreases intramyocellular lipid content (myosteatosis) and increases muscle density, improving muscle quality
Sarcopenia Research: These findings suggest potential applications for investigating age-related muscle loss and conditions characterized by muscle mass decline

Metabolic and Lipid Profile Research

Tesamorelin’s effects extend to multiple metabolic parameters:

Lipid Improvements: Studies have demonstrated reductions in triglycerides and improvements in lipid profiles
Glucose Homeostasis: Importantly, tesamorelin maintains a neutral glycemic profile without worsening insulin resistance
Non-HIV Populations: Research in non-HIV individuals with abdominal obesity showed significant VAT reduction and improved lipid profiles, suggesting benefits are not limited to specific disease states

HIV-Associated Lipodystrophy Research

As the condition for which tesamorelin received FDA approval, HIV-associated lipodystrophy remains a primary research application. This syndrome affects 8-84% of patients on antiretroviral therapy and is characterized by abnormal fat redistribution, metabolic complications, body image concerns, and increased cardiovascular risks . Tesamorelin’s ability to restore GH pulsatility—which is frequently reduced in this population—makes it particularly relevant for studying this condition .

Aging and Neuroendocrine Research

Age-related decline in GH secretion (somatopause) is associated with reduced cellular repair, bone density loss, and decreased cognitive vitality. Tesamorelin’s ability to restore GH pulsatility makes it valuable for investigating strategies to mitigate age-related decline and for studying growth hormone dynamics, muscle preservation, and metabolic balance in aging models .

Quality Assurance: Setting the Standard for Research Compounds

Manufacturing Excellence

eupeptidelap.co.uk sources Tesamorelin 5mg from certified GMP facilities with rigorous quality control protocols:

HPLC Purity Analysis: ≥99% purity verified by high-performance liquid chromatography, with some suppliers reporting >99.1% purity
Mass Spectrometry Verification: Molecular weight confirmation (5135.9 g/mol) via LC-HRMS
Batch-Specific Certificates of Analysis: Complete documentation for each production run
Third-Party Testing: Independent verification including endotoxin and elemental impurity screening
Research-Use Only (RUO) Labeling: Full compliance with research compound regulations

Chemical and Product Specifications

Specification	Detail
Product Name	Tesamorelin (TH9507, GHRH Analog)
CAS Number	218949-48-5
Molecular Formula	C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight	5135.9 g/mol
Amino Acid Length	44 amino acids
Purity	≥99% (HPLC verified)
Appearance	White to off-white lyophilized powder
Form	Lyophilized powder in sterile vials
Solubility	Soluble in sterile water or aqueous buffers
Storage (Lyophilized)	≤6°C to -20°C; protect from light, heat, and moisture
Half-Life	Approximately 11 minutes
Bioavailability	<4% after subcutaneous administration
Intended Use	Research and laboratory use only
Documentation	Certificate of Analysis provided with each batch

Stability and Handling Guidelines

Lyophilized Powder Storage: Store lyophilized tesamorelin powder at -20°C or at ≤6°C in a dry, dark environment, protected from light, heat, and moisture . Under proper storage conditions, the powder maintains stability for up to 24 months from the date of manufacture. Buy Tesamorelin 5mg Online EU & UK

Reconstitution Protocol:

Allow vial and solvent to reach ambient temperature before opening to prevent condensation
Reconstitute using sterile 18MΩ-cm H₂O or bacteriostatic water according to research protocol
Inject solvent slowly down the inside wall of the vial to minimize foaming
Gently swirl or roll the vial until fully dissolved—do not shake vigorously
Label the vial with the date of reconstitution
Refrigerate immediately at 2-8°C

Reconstituted Solution Storage: Store reconstituted tesamorelin at 2-8°C for short-term use (typically 2-7 days). For longer-term storage, aliquot into single-use portions and store at -80°C. Avoid repeated freeze-thaw cycles as this can degrade the peptide. Buy Tesamorelin 5mg Online EU & UK

Protection from Light and Moisture:

Store in original packaging protected from light
Keep vials tightly sealed when not in use
Allow refrigerated vials to reach room temperature before opening to prevent condensation

Key Benefits

Premium Quality Manufacturing: GMP-certified production, ≥99% HPLC-verified purity with lot-specific COAs
Clinically Validated Peptide: FDA-approved for HIV-associated lipodystrophy; extensively studied in over 800 patients in Phase 3 trials
Selective VAT Reduction: Reduces visceral adipose tissue by -27.71 cm² in meta-analysis (P < 0.001)
Hepatic Fat Reduction: Decreases hepatic fat percentage by -4.28% (P < 0.001)
Lean Mass Preservation: Increases lean body mass by 1.42 kg (P < 0.001)
Pulsatile GH Secretion: Restores physiological GH pulsatility rather than continuous elevation
Pituitary Selectivity: No significant effects on TSH, LH, ACTH, or prolactin
Metabolic Research: Ideal for studying visceral adiposity, lipodystrophy, and body composition
MASLD/NAFLD Research: Significant hepatic fat reduction for liver disease studies
Aging Research: Potential applications in somatopause and age-related endocrine decline
Muscle Quality Research: Decreases myosteatosis and improves muscle density
Well-Characterized Safety Profile: Favorable safety profile in clinical trials with mild to moderate, manageable adverse events
Lipid Profile Improvement: Reduces triglycerides and improves lipid parameters
Neutral Glycemic Effects: No significant perturbation of glucose homeostasis
Growth Hormone Research: Valuable tool for investigating GH-IGF-1 axis dynamics
Comprehensive Documentation: Certificates of Analysis with batch-specific purity data
48-Hour EU & UK Delivery: Rapid shipping to research facilities across Europe
Batch Consistency: Rigorous quality control ensures lot-to-lot reproducibility
EU Sourced: Available from within the European Union

Frequently Asked Questions

Q: What is Tesamorelin and how does it work?

A: Tesamorelin is a synthetic 44-amino acid analogue of growth hormone-releasing hormone (GHRH) engineered with a stabilizing modification that enhances its resistance to enzymatic degradation . It works by binding to GHRH receptors on pituitary somatotroph cells, stimulating the synthesis and pulsatile release of endogenous growth hormone . This pulsatile pattern mimics natural GH secretion, leading to increased IGF-1 production and subsequent effects on adipose tissue, muscle, and metabolism .

Q: What is the difference between Tesamorelin and Sermorelin?

A: Sermorelin represents only the first 29 amino acids of the GHRH sequence, while Tesamorelin contains the full 44-amino acid sequence plus a stabilizing modification. This structural difference makes Tesamorelin significantly more potent and stable, with a longer half-life and more sustained effect compared to Sermorelin .

Q: What purity level can I expect when I buy Tesamorelin from eupeptidelap.co.uk?

A: All Tesamorelin 5mg from eupeptidelap.co.uk is tested to ≥99% purity by HPLC, with some batches achieving >99.1% purity . Each batch is individually analyzed, and Certificates of Analysis are provided with every order, ensuring you receive material suitable for rigorous research applications.

Q: What is the molecular weight and CAS number of Tesamorelin?

A: Tesamorelin has a molecular weight of approximately 5135.9 g/mol and CAS number 218949-48-5 . Its molecular formula is C₂₂₁H₃₆₆N₇₂O₆₇S .

Q: What research areas commonly use Tesamorelin?

A: Tesamorelin is widely used in visceral adipose tissue (VAT) research, hepatic fat and MASLD/NAFLD studies, body composition research, HIV-associated lipodystrophy research, metabolic and lipid profile studies, aging and somatopause research, and growth hormone dynamics investigations .

Q: How should I store Tesamorelin for long-term stability?

A: Store lyophilized tesamorelin powder at -20°C or ≤6°C in a dry, dark environment, protected from light, heat, and moisture . Under proper storage conditions, the powder maintains stability for up to 24 months from the date of manufacture. After reconstitution, store at 2-8°C for short-term use (2-7 days) and aliquot into single-use portions for longer-term storage at -80°C.

Q: What is the half-life of Tesamorelin?

A: The mean elimination half-life of tesamorelin is approximately 11 minutes in healthy subjects after subcutaneous administration . Despite this short plasma half-life, its effects on GH pulsatility and downstream metabolic processes persist much longer due to the biological cascade it initiates.

Q: Does Tesamorelin affect other pituitary hormones?

A: No. Clinical trials have demonstrated no clinically significant changes in levels of other pituitary hormones, including thyroid-stimulating hormone (TSH), luteinizing hormone (LH), adrenocorticotropic hormone (ACTH), and prolactin, making it highly selective for the GH axis .

Q: What is the evidence for Tesamorelin’s effects on visceral fat?

A: A comprehensive 2026 meta-analysis of randomized controlled trials demonstrated that tesamorelin significantly reduces visceral adipose tissue (mean difference = -27.71 cm², 95% CI [-38.37, -17.06]; P < 0.001), trunk fat (-1.18 kg), waist circumference (-1.61 cm), and hepatic fat percentage (-4.28%) . Phase 3 trials showed average VAT reductions of 15-18% over 26 weeks .

Q: Do you ship Tesamorelin to EU countries?

A: Yes. As a dedicated EU peptide supplier, we ship Tesamorelin 5mg to all European Union member states with our guaranteed 48 hour delivery peptide service. Our EU fulfilment centre ensures rapid delivery without customs delays. All shipments use protective packaging to maintain compound integrity during transit.

Q: What documentation do you provide with Tesamorelin orders?

A: Every order includes a Certificate of Analysis (COA) with batch-specific purity data . Additional documentation, including HPLC chromatograms and mass spectrometry data, is available upon request for researchers requiring comprehensive analytical verification.

Q: Does Tesamorelin have applications in non-HIV research?

A: Yes. Research in non-HIV individuals with abdominal obesity has shown similar benefits, including significant VAT reduction and improved lipid profiles, suggesting tesamorelin’s effects are not limited to specific disease states but are a direct result of its mechanism of action on the GH axis .

Q: What are the common adverse effects observed in Tesamorelin clinical trials?

A: Common adverse events include injection site reactions (redness, pain, itching), arthralgia (joint pain), myalgia (muscle pain), peripheral edema, and paresthesia . These effects are generally mild to moderate and manageable. Anti-tesamorelin antibodies developed in approximately 50% of patients, but antibody status did not affect treatment efficacy .

Q: Do you offer bulk quantities of Tesamorelin for institutional research?

A: Yes. We accommodate bulk orders for research institutions. Contact our team at sales@eupeptidelap.co.uk for volume pricing, custom requirements, and supply agreements for ongoing research programs. ...........................................

Advance Your Research with Tesamorelin 5mg

eupeptidelap.co.uk is your trusted source for Tesamorelin 5mg, the premium choice for researchers investigating visceral adiposity, metabolic disorders, hepatic fat accumulation, and growth hormone dynamics. With over a decade of clinical research, FDA approval for HIV-associated lipodystrophy, and extensive peer-reviewed literature supporting its metabolic effects, tesamorelin represents one of the most clinically validated GHRH analogs in the research community .

Whether you are exploring visceral fat reduction mechanisms, designing MASLD/NAFLD studies, investigating body composition changes, or researching age-related endocrine decline, our rigorously tested compound provides the quality and consistency your work demands. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Order today and experience the eupeptidelap.co.uk difference – premium quality, rapid 48-hour delivery across the EU and UK, and expert support for the European research community.